Advent strikes $4.8 billion deal to sell Zentiva to GTCR, FT reports

Zentiva as

11/09/2025 04:18

Sept 10 (Reuters) - GTCR has struck a 4.1 billion-euro ($4.80 billion) deal to buy Czech generic drug maker Zentiva 1SKF401E.BV from Advent International, the Financial Times reported on Wednesday, citing two people familiar with the matter.

Reuters could not immediately confirm the report.

($1 = 0.8548 euros)

 (Reporting by Gnaneshwar Rajan in Bengaluru; Editing by Sonia Cheema)

 ((Gnaneshwar.Rajan@thomsonreuters.com;))